Brilinta shows promise in phase III clinical trial
Results of a phase III clinical trial suggest that dual antiplatelet therapy may improve outcomes for patients with established coronary artery disease (CAD) and type 2 diabetes....
List view / Grid view
Results of a phase III clinical trial suggest that dual antiplatelet therapy may improve outcomes for patients with established coronary artery disease (CAD) and type 2 diabetes....
The Bio-Process Systems Alliance, the primary international industry association for single-use bio-processing, is pleased to announce the release of its latest whitepaper...
General Electric is selling its biopharma business for $21.4 billion, with shares in the company jumping 16 percent upon the news...
The European Medicines Agency (EMA) has lost a High Court case, meaning it will have to pay the remaining 20 years left on the lease...
US researchers have created a proof-of-concept method for ensuring the integrity of clinical trials data using blockchain...
A method commonly used in lithium-ion batteries has been developed to help the safer and cheaper manufacture of medicines...
The EU is adopting new rules which should boost the competitiveness of EU producers of generic medicines and biosimilar products...
A study has shown that a 'smart drug' that delivers a toxic payload directly to tumour cells could be a possible treatment for breast cancer...
A report has forecasted that the generic oncology drugs market could register an impressive 6 percent CAGR up to the year 2028...
A study has shown how structural barriers are one of the main reasons why clinical trials often do not meet their enrolment targets...
A study has found that the FDA failed to design and implement an effective monitoring program for Transmucosal Immediate-Release Fentanyls...
Researchers have found that fluconazole used to treat yeast infections in pregnant women could cause a higher risk of miscarriage...
Immunotherapy drug plus targeted agent provided better progression-free survival and shrank tumors in more patients than standard one-drug treatment...
Simplify your artwork process, get closer to your customers and strengthen compliance...
A UK based biotech firm has been awarded a grant to develop a treatment for osteoarthritis, after promising results from a Phase I trial...